drugset
drugset / Trial / NCT04756154

Efficacy Study of Patient Preoperative Preps In-vivo

NCT04756154 ↗

Phase 3 Completed 154 enrolled Solventum US LLC 3M · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine the antimicrobial efficacy of an investigational CHG/IPA prep on skin flora of the inguinal regions of human subjects.

Timeline

Start
2020-07-06
Primary completion
2021-04-28
Completion
2021-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject CHG/IPA Unknown 2 % Topical
Subject CHG/IPA Unknown 70 % Topical

Indications

No indication recorded.